O’Hanlon S. J., Slater H. C., Cheke R. A., Boatin B. A., Coffeng L. E., Pion S. D. S., Boussinesq M., Zouré H. G. M., Stolk W. A., et Basáñez M.-G.,
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa,
PLOS Neglected Tropical Diseases, vol. 10, no 1, p. e0004328, janv. 2016. doi: 10.1371/journal.pntd.0004328.

Boillot F., Serrano L., Muwonga J., Kabuayi J. P., Kambale A., Mutaka F., Fujiwara P. I., Decosas J., Peeters M., et Delaporte E.,
Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo,
J Acquir Immune Defic Syndr, vol. 71, no 1, p. e9‑e15, janv. 2016. doi: 10.1097/QAI.0000000000000844.

Asangbeh S. L., Sobngwi J. L., Ekali G. L., Eyoum C., et Msellati P.,
Predictors of depression among patients on art in a rural health district in North West Cameroon,
AIDS Care, vol. 28, no 2, p. 205‑208, févr. 2016. doi: 10.1080/09540121.2015.1074654.

Nansumba M., Kumbakumba E., Orikiriza P., Muller Y., Nackers F., Debeaudrap P., Boum Y., et Bonnet M.,
Detection Yield and Tolerability of String Test for Diagnosis of Childhood Intrathoracic Tuberculosis,
The Pediatric Infectious Disease Journal, vol. 35, no 2, p. 146‑151, févr. 2016. doi: 10.1097/INF.0000000000000956.

Piroth L., Moinot L., Yeni P., Avettand-Fénoel V., Reynes J., Girard P.-M., Marchou B., Georget A., Rouzioux C., Autran B., Duvillard L., Chêne G., et Fagard C.,
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial),
Journal of Antimicrobial Chemotherapy, vol. 71, no 2, p. 490‑496, févr. 2016. doi: 10.1093/jac/dkv369.

Barankanira E., Molinari N., Niyongabo T., et Laurent C.,
Spatial analysis of HIV infection and associated individual characteristics in Burundi: indications for effective prevention,
BMC Public Health, vol. 16, p. 118, 2016. doi: 10.1186/s12889-016-2760-3.

Makinson A., Eymard-Duvernay S., Raffi F., Abgrall S., Bommart S., Zucman D., Valour F., Cheret A., Poizot-Martin I., Duvivier C., Mauboussin J.-M., Bonnet F., Tattevin P., Reynes J., Le Moing V., et ANRS EP48 HIV CHEST study Team,
Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers,
AIDS, vol. 30, no 4, p. 573‑582, févr. 2016. doi: 10.1097/QAD.0000000000000943.

Maman D., Chilima B., Masiku C., Ayouba A., Masson S., Szumilin E., Peeters M., Ford N., Heinzelmann A., Riche B., et Etard J.-F.,
Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study
J Int AIDS Soc, vol. 19, no 1, p. 20673, 2016.

Nguyen T. T., Niloofar R., Rubbo P.-A., Nils K., Bollore K., Ducos J., Pageaux G.-P., Reynes J., Van de Perre P., et Tuaillon E.,
Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy,
Mediterr J Hematol Infect Dis, vol. 8, no 1, p. e2016003, 2016. doi: 10.4084/MJHID.2016.003.

Maria A. T., Maquart M., Makinson A., Flusin O., Segondy M., Leparc-Goffart I., Le Moing V., et Foulongne V.,
Zika virus infections in three travellers returning from South America and the Caribbean respectively, to Montpellier, France, December 2015 to January 2016,
Euro Surveill., vol. 21, no 6, févr. 2016. doi: 10.2807/1560-7917.ES.2016.21.6.30131.

Marcy O., Ung V., Goyet S., Borand L., Msellati P., Tejiokem M., Nguyen Thi N. L., Nacro B., Cheng S., Eyangoh S., Pham T. H., Ouedraogo A.-S., Tarantola A., Godreuil S., Blanche S., Delacourt C., et PAANTHER study group,
Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children,
Clin. Infect. Dis., févr. 2016. doi: 10.1093/cid/ciw036.

Chang E. W., Page A.-L., et Bonnet M.,
Light-emitting diode fluorescence microscopy for tuberculosis diagnosis: a meta-analysis,
Eur.Respir. J., déc. 2015. doi: 10.1183/13993003.00978-2015.

Msellati P., Ateba Ndongo F., Hejoaka F., et Nacro B.,
Impediments to HIV testing in HIV-infected children and teenagers in Africa: look for them where they are!,
Med Sante Trop, mars 2016. doi: 10.1684/mst.2015.0519.

Huerga H., Mueller Y., Ferlazzo G., Mpala Q., Bevilacqua P., Vasquez B., Noël Mekiedje C., Ouattara A., Mchunu G., Weyenga H. O., Varaine F., et Bonnet M.,
Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings,
J. Acquir. Immune Defic. Syndr., vol. 71, no 4, p. e89-95, avr. 2016. doi: 10.1097/QAI.0000000000000895.

Galy A., Ciaffi L., Le Moing V., Eymard-Duvernay S., Abessolo H., Toby R., Ayangma L., Le Gac S., Mpoudi-Etame M., Koulla-Shiro S., Delaporte E., Cournil A., the, et Group L. S.,
Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon,
Antivir. Ther. (Lond.), févr. 2016. doi: 10.3851/IMP3030.

Desclaux A., Ndione A. G., Badji D., et Sow K.,
La surveillance des personnes contacts pour Ébola : effets sociaux et enjeux éthiques au Sénégal,
Bull. Soc. Pathol. Exot., p. 1‑7, févr. 2016. doi: 10.1007/s13149-016-0477-2.

Mostafa A., Shimakawa Y., Medhat A., Mikhail N. N., Chesnais C. B., Arafa N., Bakr I., El Hoseiny M., El-Daly M., Esmat G., Abdel-Hamid M., Mohamed M. K., et Fontanet A.,
Excess mortality rate associated with hepatitis C virus infection: A community-based cohort study in rural Egypt,
J. Hepatol., vol. 64, no 6, p. 1240‑1246, juin 2016. doi: 10.1016/j.jhep.2016.02.033.

Sundararaman S. A., Plenderleith L. J., Liu W., Loy D. E., Learn G. H., Li Y., Shaw K. S., Ayouba A., Peeters M., Speede S., Shaw G. M., Bushman F. D., Brisson D., Rayner J. C., Sharp P. M., et Hahn B. H.,
Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria,
Nat Commun, vol. 7, p. 11078, 2016. doi: 10.1038/ncomms11078.

Boum Y., Kim S., Orikiriza P., Acuña-Villaorduña C., Vinhas S., Bonnet M., Nyehangane D., Mwanga-Amumpaire J., Fennelly K. P., et Jones-López E. C.,
Diagnostic Accuracy of the Small Membrane Filtration Method for Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting,
J. Clin. Microbiol., mars 2016. doi: 10.1128/JCM.00017-16.

Drame P. M., Montavon C., Pion S. D., Kubofcik J., Fay M. P., et Nutman T. B.,
Molecular Epidemiology of Blood-Borne Human Parasites in a Loa loa-, Mansonella perstans-, and Plasmodium falciparum-Endemic Region of Cameroon,
Am. J. Trop. Med. Hyg., vol. 94, no 6, p. 1301‑1308, juin 2016. doi: 10.4269/ajtmh.15-0746.

Mueller Y. K., Bastard M., Nkemenang P., Comte E., Ehounou G., Eyangoh S., Rusch B., Tabah E. N., Trellu L. T., et Etard J.-F.,
The « Buruli Score »: Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon,
PLoS Negl Trop Dis, vol. 10, no 4, p. e0004593, avr. 2016. doi: 10.1371/journal.pntd.0004593.

Toutous Trellu L., Nkemenang P., Comte E., Ehounou G., Atangana P., Mboua D. J., Rusch B., Njih Tabah E., Etard J.-F., et Mueller Y. K.,
Differential Diagnosis of Skin Ulcers in a Mycobacterium ulcerans Endemic Area: Data from a Prospective Study in Cameroon,
PLoS Negl Trop Dis, vol. 10, no 4, p. e0004385, avr. 2016. doi: 10.1371/journal.pntd.0004385.

Tubiana S., Duval X., Alla F., Selton-Suty C., Tattevin P., Delahaye F., Piroth L., Chirouze C., Lavigne J.-P., Erpelding M.-L., Hoen B., Vandenesch F., Iung B., Le Moing V., et VIRSTA/AEPEI Study Group,
The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia,
J. Infect., vol. 72, no 5, p. 544‑553, mai 2016. doi: 10.1016/j.jinf.2016.02.003.

Launay O., Rosenberg A. R., Rey D., Pouget N., Michel M.-L., Reynes J., Neau D., Raffi F., Piroth L., Carrat F., et ANRS HB03 VIHVAC-B (Trial Comparing 3 Strategies of Vaccination Against the Virus of Hepatitis B in HIV-Infected Patients) Group,
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial,
JAMA Intern Med, avr. 2016. doi: 10.1001/jamainternmed.2016.0741.

Blaizot S., Maman D., Riche B., Mukui I., Kirubi B., Ecochard R., et Etard J.-F.,
Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study,
BMC Infect. Dis., vol. 16, no 1, p. 189, 2016. doi: 10.1186/s12879-016-1520-4.

Kammalac Ngouana T., Drakulovski P., Krasteva D., Kouanfack C., Reynes J., Delaporte E., Boyom F. F., Mallié M., et Bertout S.
Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient,
Journal of Medical Microbiology, vol. 65, no 7, p. 579‑589, 2016. doi: 10.1099/jmm.0.000265.

Batisse A., Peyrière H., Eiden C., Courné M.-A., Djezzar S., et Réseau français des centres d’addictovigilance,
[Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers],
Therapie, vol. 71, no 5, p. 447‑455, oct. 2016. doi: 10.1016/j.therap.2016.04.003.

Riche B., Bricout H., Kürzinger M.-L., Roche S., Iwaz J., Etard J.-F., et Ecochard R.,
Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns,
Expert Rev Vaccines, mai 2016. doi: 10.1080/14760584.2016.1183483.

Sow M. S., Etard J.-F., Baize S., Magassouba N., Faye O., Msellati P., Touré A. I., Savane I., Barry M., Delaporte E., et Postebogui Study Group,
New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors,
J. Infect. Dis., mai 2016. doi: 10.1093/infdis/jiw078.

Mir D., Jung M., Delatorre E., Vidal N., Peeters M., et Bello G.,
Phylodynamics of the major HIV-1 CRF02_AG African lineages and its global dissemination,
Infect. Genet. Evol., mai 2016. doi: 10.1016/j.meegid.2016.05.017.

Salou M., Dagnra A. Y., Butel C., Vidal N., Serrano L., Takassi E., Konou A. A., Houndenou S., Dapam N., Singo-Tokofaï A., Pitche P., Atakouma Y., Prince-David M., Delaporte E., et Peeters M.,
High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo
J Int AIDS Soc, vol. 19, no 1, p. 20683, 2016.

Salou M., Butel C., Konou A. A., Ekouevi D. K., Vidal N., Dossim S., Lawson-Evi K., Nyasenu Y. T., Singo-Tokofaï A., d’Almeida S., Tchama R., Delaporte E., Prince-David M., Peeters M., et Dagnra A. Y.,
High Rates of Drug Resistance Among Newly Diagnosed HIV-Infected Children in the National Prevention of Mother-To-Child Transmission Program in Togo,
Pediatr. Infect. Dis. J., mai 2016. doi: 10.1097/INF.0000000000001203.

Konou A. A., Vidal N., Salou M., Anato S., Singo-Tokofaï A., Ekouevi D. K., Pitché P., Prince-David M., Delaporte E., Peeters M., et Dagnra A. Y.,
Genetic diversity and transmission networks of HIV-1 strains among men having sex with men (MSM) in Lomé, Togo,
Infect. Genet. Evol., mai 2016. doi: 10.1016/j.meegid.2016.05.030.

Chesnais C. B., Vlaminck J., Kunyu-Shako B., Pion S. D., Awaca-Uvon N.-P., Weil G. J., Mumba D., et Boussinesq M.,
Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer,
Am. J. Trop. Med. Hyg., avr. 2016. doi: 10.4269/ajtmh.15-0916.

Huerga H., Van Cutsem G., Ben Farhat J., Reid M., Bouhenia M., Maman D., Wiesner L., Etard J.-F., et Ellman T.,
Who needs to be targeted for HIV testing and treatment in KwaZulu-Natal? Results from a population-based survey,
J. Acquir. Immune Defic. Syndr., mai 2016. doi: 10.1097/QAI.0000000000001081.

Chesnais C. B., Sabbagh A., Pion S. D., Missamou F., Garcia A., et Boussinesq M.,
Familial aggregation and heritability of Wuchereria bancrofti infection,
J. Infect.Dis., mai 2016. doi: 10.1093/infdis/jiw212.

Liu W., Sundararaman S. A., Loy D. E., Learn G. H., Li Y., Plenderleith L. J., Ndjango J.-B. N., Speede S., Atencia R., Cox D., Shaw G. M., Ayouba A., Peeters M., Rayner J. C., Hahn B. H., et Sharp P. M.,
Multigenomic Delineation of Plasmodium Species of the Laverania Subgenus Infecting Wild-living Chimpanzees and Gorillas,
Genome Biol Evol, juin 2016. doi: 10.1093/gbe/evw128.

Guichet E., Aghokeng A. F., Serrano L., Bado G., Toure-Kane C., Eymard-Duvernay S., Villabona-Arenas C.-J., Delaporte E., Ciaffi L., et Peeters M.,
High viral load and multidrug resistance due to late switch to second-line regimens could be a major obstacle to reach the 90-90-90 UNAIDS objectives in sub-Saharan Africa,
AIDS Res. Hum. Retroviruses, juin 2016. doi: 10.1089/AID.2016.0010.

Tekle A. H., Zouré H. G. M., Noma M., Boussinesq M., Coffeng L. E., Stolk W. A., et Remme J. H. F.,
Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results,
Infect Dis Poverty, vol. 5, no 1, p. 66, 2016. doi: 10.1186/s40249-016-0160-7.

Faucher J.-F., Morquin D., Reynes J., Chirouze C., Hoen B., et Le Moing V.,
Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection,
Parasitol. Int., vol. 65, no 5 Pt A, p. 444‑446, juin 2016. doi: 10.1016/j.parint.2016.06.009.

Bonnet M., Bastard M., du Cros P., Khamraev A., Kimenye K., Khurkhumal S., Hayrapetyan A., Themba D., Telnov A., Sanchez-Padilla E., Hewison C., et Varaine F.,
Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study,
Int. J. Tuberc. Lung Dis., vol. 20, no 2, p. 177‑186, févr. 2016. doi: 10.5588/ijtld.15.0962.

Cooper D. A., Cordery D. V., Zajdenverg R., Ruxrungtham K., Arastéh K., Bergmann F., Neto J. L. de A., Scherer J., Chaves R. L., Robinson P., et study team,
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial,
PLoS ONE, vol. 11, no 1, p. e0144917, 2016. doi: 10.1371/journal.pone.0144917.

Selton-Suty C., Delahaye F., Tattevin P., Federspiel C., Le Moing V., Chirouze C., Nazeyrollas P., Vernet-Garnier V., Bernard Y., Chocron S., Obadia J.-F., Alla F., Hoen B., Duval X., et AEPEI (Association pour l’Etude et la Prévention de l’Endocardite Infectieuse),
Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis,
PLoS ONE, vol. 11, no 7, p. e0158522, 2016. doi: 10.1371/journal.pone.0158522.

Psomas C., Younas M., Reynes C., Cezar R., Portalès P., Tuaillon E., Guigues A., Merle C., Atoui N., Fernandez C., Le Moing V., Barbuat C., Marin G., Nagot N., Sotto A., Eliaou J.-F., Sabatier R., Reynes J., et Corbeau P.,
One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study,
EBioMedicine, vol. 8, p. 265‑276, juin 2016. doi: 10.1016/j.ebiom.2016.05.008.

Psomas C., Younas M., Reynes C., Cezar R., Portalès P., Tuaillon E., Guigues A., Merle C., Atoui N., Fernandez C., Le Moing V., Barbuat C., Marin G., Nagot N., Sotto A., Eliaou J.-F., Sabatier R., Reynes J., et Corbeau P.,
Corrigendum to « One of the Immune Activation Profiles Observed in HIV-1-Infected Adults with Suppressed Viremia is Linked to Metabolic Syndrome: The ACTIVIH Study » [EBioMedicine 8 (2016) 265-276],
EBioMedicine, août 2016. doi: 10.1016/j.ebiom.2016.08.003.

Madinda N. F., Ehlers B., Wertheim J. O., Akoua-Koffi C., Bergl R. A., Boesch C., Boji Mungu Akonkwa D., Eckardt W., Fruth B., Gillespie T. R., Gray M., Hohmann G., Karhemere S., Kujirakwinja D., Langergraber K., Muyembe J.-J., Nishuli R., Pauly M., Petrzelkova K. J., Robbins M. M., Todd A., Schubert G., Stoinski T. S., Wittig R. M., Zuberbühler K., Peeters M., Leendertz F. H., et Calvignac-Spencer S.,
Assessing host-virus co-divergence for close relatives of Merkel cell polyomavirus infecting African great apes,
J. Virol., juill. 2016. doi: 10.1128/JVI.00247-16.

Moeller A. H., Caro-Quintero A., Mjungu D., Georgiev A. V., Lonsdorf E. V., Muller M. N., Pusey A. E., Peeters M., Hahn B. H., et Ochman H.,
Cospeciation of gut microbiota with hominids,
Science, vol. 353, no 6297, p. 380‑382, juill. 2016. doi: 10.1126/science.aaf3951.

Kassi F. K., Drakulovski P., Bellet V., Krasteva D., Gatchitch F., Doumbia A., Kouakou G. A., Delaporte E., Reynes J., Mallié M., Menan H. I. E., et Bertout S.,
Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients,
Mycoses, juill. 2016. doi: 10.1111/myc.12539.

Locatelli S., Harrigan R. J., Sesink Clee P. R., Mitchell M. W., McKean K. A., Smith T. B., et Gonder M. K.,
Why Are Nigeria-Cameroon Chimpanzees (Pan troglodytes ellioti) Free of SIVcpz Infection?,
PLoS ONE, vol. 11, no 8, p. e0160788, 2016. doi: 10.1371/journal.pone.0160788.

Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord,
Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies,
Clin. Infect. Dis., août 2016. doi: 10.1093/cid/ciw562.

Sandeu M. M., Abate L., Tchioffo M. T., Bayibéki A. N., Awono-Ambéné P. H., Nsango S. E., Chesnais C. B., Dinglasan R. R., de Meeûs T., et Morlais I.,
Impact of exposure to mosquito transmission-blocking antibodies on Plasmodium falciparum population genetic structure,
Infect. Genet. Evol., août 2016. doi: 10.1016/j.meegid.2016.08.025.

Ahuka-Mundeke S., Lunguya-Metila O., Mbenzo-Abokome V., Butel C., Inogwabini B.-I., Omasombo V., Muyembe-Tamfum J.-J., Georgiev A. V., Muller M. N., Ndjango J.-B. N., Li Y., Delaporte E., Hahn B. H., Peeters M., et Ayouba A.,
Genetic diversity of STLV-2 and interspecies transmission of STLV-3 in wild-living bonobos,
Virus Evol, vol. 2, no 1, p. vew011, janv. 2016. doi: 10.1093/ve/vew011.

Sigel K., Makinson A., et Thaler J.,
Lung cancer in persons with HIV,
Curr Opin HIV AIDS, sept. 2016. doi: 10.1097/COH.0000000000000326.

Braquet P., Alla F., Cornu C., Goehringer F., Piroth L., Chirouze C., Revest M., Lechiche C., Duval X., Le Moing V., et VIRSTA-AEPEI study group,
Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study,
Clin. Microbiol. Infect., août 2016. doi: 10.1016/j.cmi.2016.07.034.

Cogliati M., D’Amicis R., Zani A., Montagna M. T., Caggiano G., De Giglio O., Balbino S., De Donno A., Serio F., Susever S., Ergin C., Velegraki A., Ellabib M. S., Nardoni S., Macci C., Oliveri S., Trovato L., Dipineto L., Rickerts V., McCormick-Smith I., Akcaglar S., Tore O., Mlinaric-Missoni E., Bertout S., Mallié M., Martins M. da L., Vencà A. C. F., Vieira M. L., Sampaio A. C., Pereira C., Griseo G., Romeo O., Ranque S., Al-Yasiri M. H. Y., Kaya M., Cerikcioglu N., Marchese A., Vezzulli L., Ilkit M., Desnos-Ollivier M., Pasquale V., Korem M., Polacheck I., Scopa A., Meyer W., Ferreira-Paim K., Hagen F., Theelen B., Boekhout T., Lockhart S. R., Tintelnot K., Tortorano A. M., Dromer F., Varma A., Kwon-Chung K. J., Inácio J., Alonso B., et Colom M. F.,
Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin,
FEMS Yeast Res., vol. 16, no 4, juin 2016. doi: 10.1093/femsyr/fow045.

Taieb F., Tram T. H., Ho H. T., Pham V. A., Nguyen L., Pham B. H., Tong L. A., Tuaillon E., Delaporte E., Nguyen A. T., Bui D. D., Do N., et Madec Y.,
Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338),
Open Forum Infect Dis, vol. 3, no 3, p. ofw142, sept. 2016. doi: 10.1093/ofid/ofw142.

Makinson A., Le Moing V., Reynes J., Ferry T., Lavole A., Poizot-Martin I., Pujol J.-L., Spano J.-P., et Milleron B.,
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV. A Review by the Multidisciplinary CANCERVIH Working Group,
J Thorac Oncol, juill. 2016. doi: 10.1016/j.jtho.2016.06.026.

Raffi F., Le Moing V., Assuied A., Habak S., Spire B., Cazanave C., Billaud E., Dellamonica P., Ferry T., Fagard C., Leport C., et and the ANRS CO8 COPILOTE Study Group,
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course,
J. Antimicrob. Chemother., sept. 2016. doi: 10.1093/jac/dkw369.

Hema M. N., Ferry T., Dupon M., Cuzin L., Verdon R., Thiébaut R., Protopopescu C., Leport C., Raffi F., Le Moing V., et ANRS CO 8 (APROCO/COPILOTE) study group
Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study,
PLoS ONE, vol. 11, no 8, p. e0161594, 2016. doi: 10.1371/journal.pone.0161594.

Iung B., Doco-Lecompte T., Chocron S., Strady C., Delahaye F., Le Moing V., Poyart C., Alla F., Cambau E., Tattevin P., Chirouze C., Obadia J.-F., Duval X., Hoen B., et AEPEI Study Group,
Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices,
Eur. Heart J., vol. 37, no 10, p. 840‑848, mars 2016. doi: 10.1093/eurheartj/ehv650.

Guichet E., Aghokeng A., Eymard-Duvernay S., Vidal N., Ayouba A., Ngole E. M., Delaporte E., Ciaffi L., et Peeters M.,
Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon,
J. Virol. Methods, sept. 2016. doi: 10.1016/j.jviromet.2016.09.005.

Msellati P., Touré A., Sow M. S., Cécé K., Taverne B., Desclaux A., Barry M., Etard J.-F., Delaporte E., et Groupe d’études PostEboGui,
[Revival after Ebola: Multidisciplinary assessment at 1 year, prospect and follow-up study of surviving patients from Ebola in Guinea (PostEboGui cohort)],
Bull Soc Pathol Exot, oct. 2016. doi: 10.1007/s13149-016-0526-x.

Heigele A., Kmiec D., Regensburger K., Langer S., Peiffer L., Stürzel C. M., Sauter D., Peeters M., Pizzato M., Learn G. H., Hahn B. H., et Kirchhoff F.,
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild,
Cell Host Microbe, vol. 20, no 3, p. 381‑391, sept. 2016. doi: 10.1016/j.chom.2016.08.004.

Cournil A., Hema A., Eymard-Duvernay S., Ciaffi L., Badiou S., Kabore F. N., Diouf A., Ayangma L., Le Moing V., Reynes J., Koulla-Shiro S., Delaporte E., et 2LADY Study Group,
Evolution of renal function in African patients initiating second line antiretroviral treatment: findings from the 2LADY-ANRS 12169 trial,
Antivir. Ther. (Lond.), oct. 2016. doi: 10.3851/IMP3097.

Pion S. D., Montavon C., Chesnais C. B., Kamgno J., Wanji S., Klion A. D., Nutman T. B., et Boussinesq M.,
Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia,
Am. J. Trop. Med. Hyg., oct. 2016. doi: 10.4269/ajtmh.16-0547.

Ngouana T. K., Drakulovski P., Krasteva D., Toghueo R. K., Kouanfack C., Reynes J., Delaporte E., Boyom F. F., Mallié M., et Bertout S.,
Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV-infected patients,
Med. Mycol., oct. 2016. doi: 10.1093/mmy/myw108.

Grandesso F., Nabasumba C., Nyehangane D., Page A.-L., Bastard M., De Smet M., Boum Y., et Etard J.-F.,
Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings,
Malar. J., vol. 15, no 1, p. 496, oct. 2016. doi: 10.1186/s12936-016-1529-6.

Villabona-Arenas C. J., Vidal N., Guichet E., Serrano L., Delaporte E., Gascuel O., et Peeters M.,
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa,
AIDS, sept. 2016. doi: 10.1097/QAD.0000000000001233.

Kassi F. K., Bellet V., Doumbia A., Krasteva D., Drakulovski P., Kouakou G. A., Gatchitch F., Delaporte E., Reynes J., Mallié M., Menan H. I. E., et Bertout S.,
First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an Ivorian HIV-positive patient,
JMM Case Reports, vol. 3, no 4, 2016. doi: 10.1099/jmmcr.0.005037.

Chesnais C. B., Takougang I., Paguélé M., Pion S. D., et Boussinesq M.,
Excess mortality associated with loiasis: a retrospective population-based cohort study,
Lancet Infect Dis, oct. 2016. doi: 10.1016/S1473-3099(16)30405-4.

Ayouba A., Touré A., Butel C., Keita A. K., Binetruy F., Sow M. S., Foulongne V., Delaporte E., et Peeters M.,
Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus,
J. Clin. Microbiol., vol. 55, no 1, p. 165‑176, janv. 2017. doi: 10.1128/JCM.01979-16.

Foley B. T., Leitner T., Paraskevis D., et Peeters M.,
Primate immunodeficiency virus classification and nomenclature: Review,
Infect. Genet. Evol., oct. 2016. doi: 10.1016/j.meegid.2016.10.018.

Maman D., Ben-Farhat J., Chilima B., Masiku C., Salumu L., Ford N., Mendiharat P., Szumilin E., Masson S., et Etard J. F.,
Factors associated with HIV status awareness and Linkage to Care following home based testing in rural Malawi,
Trop. Med. Int. Health, vol. 21, no 11, p. 1442‑1451, nov. 2016. doi: 10.1111/tmi.12772.

Denoeud-Ndam L., Dicko A., Baudin E., Guindo O., Grandesso F., Diawara H., Sissoko S., Sanogo K., Traoré S., Keita S., Barry A., de Smet M., Lasry E., Smit M., Wiesner L., Barnes K. I., Djimde A. A., Guerin P. J., Grais R. F., Doumbo O. K., et Etard J.-F.,
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger,
BMC Med, vol. 14, no 1, p. 167, oct. 2016. doi: 10.1186/s12916-016-0716-1.

Blaizot S., Kim A. A., Zeh C., Riche B., Maman D., DeCock K., Etard J.-F., et Ecochard R.,
Estimating HIV incidence using a cross-sectional survey: comparison of three approaches in a hyperendemic setting, Ndhiwa sub-county, Kenya, 2012,
AIDS Res. Hum. Retroviruses, nov. 2016. doi: 10.1089/AID.2016.0123.

Cames C., Varloteaux M., Have N. N., Diom A. B., Msellati P., Mbaye N., Mbodj H., Sy Signate H., Diack A., et ANRS 12279 MAGGSEN Cohort Study Group,
Acceptability of Outpatient Ready-To-Use Food-Based Protocols in HIV-Infected Senegalese Children and Adolescents Within the MAGGSEN Cohort Study,
Food Nutr Bull, nov. 2016. doi: 10.1177/0379572116679053.

Kamga G.-R., Dissak-Delon F. N., Nana-Djeunga H. C., Biholong B. D., Mbigha-Ghogomu S., Souopgui J., Zoure H. G. M., Boussinesq M., Kamgno J., et Robert A.,
Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment,
Parasit Vectors, vol. 9, no 1, p. 581, nov. 2016. doi: 10.1186/s13071-016-1868-8.

Makinson A. et Reynes J.,
A novel marker of lung-cancer risk in people with HIV,
Lancet HIV, déc. 2016. doi: 10.1016/S2352-3018(16)30218-1.

WWARN Gametocyte Study Group,
Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data,
BMC Med, vol. 14, p. 79, mai 2016. doi: 10.1186/s12916-016-0621-7.

Serris A., Zoungrana J., Diallo M., Toby R., Mpoudi Ngolle M., Le Gac S., Coutherut J., Cournil A., De Beaudrap P., Koulla-Shiro S., Delaporte E., et Ciaffi L.,
Getting pregnant in HIV clinical trials: women’s choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials,
HIV Clin Trials, p. 1‑9, nov. 2016. doi: 10.1080/15284336.2016.1248624.

Keita A. K., Toure A., Sow M. S., Raoul H., Magassouba N., Delaporte E., Etard J.-F., et Postebogui Study Group,
Extraordinary long term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health,
Clin. Microbiol. Infect., nov. 2016. doi: 10.1016/j.cmi.2016.11.005.

Boullé C., Guichet E., Kouanfack C., Aghokeng A., Onambany B., Ikaka C. M., Ngock E., Tsoumsta L., Msellati P., Mpoudi-Ngolé E., Peeters M., Delaporte E., et Laurent C.,
Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets ,
Open Forum Infect Dis, vol. 3, no 4, p. ofw233, oct. 2016. doi: 10.1093/ofid/ofw233.

Lanièce C., Sow K., et Desclaux A.
Les agents de sécurité en première ligne face à Ebola : rôles, perceptions et connaissances au CHU de Fann, Dakar, Sénégal
Bull. Soc. Pathol. Exot., vol. 109, no 4, p. 303‑308, oct. 2016. doi: 10.1007/s13149-016-0493-2.

Sow S., Desclaux A., et Taverne B., Groupe d’étude PostEboGui.
Ebola en Guinée : formes de la stigmatisation des acteurs de santé survivants
Bull. Soc. Pathol. Exot., vol. 109, no 4, p. 309‑313, oct. 2016. doi: 10.1007/s13149-016-0510-5.

Giles-Vernick T., Hejoaka F., Sanou A., Shimakawa Y., Bamba I., et Traoré A.,
Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa,
Am. J. Trop. Med. Hyg., vol. 95, no 6, p. 1368‑1375, déc. 2016. doi: 10.4269/ajtmh.16-0398.

Hereth Hébert E., Oury Bah M., E’tard J. F., Sow M. S., Resnikoff S., Fardeau C., Touré A., Niouma Ouendeno A., Sagno I. C., March L., Izard S., Lama P. L., Barry M., Delaporte E., et Postebogui Study Group,
Ocular complications in survivors of the Ebola outbreak in Guinea,
Am. J. Ophthalmol., déc. 2016. doi: 10.1016/j.ajo.2016.12.005.

Ayouba A., Paraskevis D., et Peeters M.,
Infect. Genet. Evol., vol. 46, p. 149, déc. 2016. doi: 10.1016/j.meegid.2016.11.017.

Micollier, E.
De résonances phénoménologiques dans le monde chinois : Corps, personne, monde et mouvement dans des expériences taoistes et du qigong
Anthropologie et sociétés, vol. 40 no 3, p. 161-185, 2016

Cames C., Pascal L., Diack A., Mbodj H., Ouattara B., Diagne N. R., Diallo N. F., Msellati P., Mbaye N., Signate H. S., et MAGGSEN Cohort Study Group,
Risk Factors for Growth Retardation in HIV-Infected Senegalese Children on Antiretroviral Treatment: The ANRS 12279 MAGGSEN Pediatric Cohort Study,
Pediatr. Infect. Dis. J., déc. 2016. doi: 10.1097/INF.0000000000001454.

Boye S.
Nourrir son enfant dans des situations de contraintes liées à la pratique de l’allaitement
Actes du symposium sur l’enfant au Sénégal, dans le cadre du plan Sénégal Émergent (PSE),Ministère de l’économie des Finances et du Plan (MEFP) et UNICEF, Dakar, 2016, p.41-46.

Kassi F. K., Drakulovski P., Bellet V., Krasteva D., Gatchitch F., Doumbia A., Kouakou G. A., Delaporte E., Reynes J., Mallié M., Menan H. I. E., et Bertout S.,
Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients,
Mycoses, vol. 59, no 12, p. 811‑817, déc. 2016. doi: 10.1111/myc.12539.